Login / Signup

Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.

Richard BeasleyMark HollidayHelen K ReddelIrene BraithwaiteStefan EbmeierRobert J HancoxTimothy HarrisonClaire HoughtonKaren OldfieldAlberto PapiIan D PavordMathew WilliamsMark Weatherallnull null
Published in: The New England journal of medicine (2019)
In an open-label trial involving adults with mild asthma, budesonide-formoterol used as needed was superior to albuterol used as needed for the prevention of asthma exacerbations. (Funded by AstraZeneca and the Health Research Council of New Zealand; Novel START Australian New Zealand Clinical Trials Registry number, ACTRN12615000999538.).
Keyphrases
  • chronic obstructive pulmonary disease
  • lung function
  • clinical trial
  • allergic rhinitis
  • study protocol
  • cystic fibrosis
  • open label
  • phase ii
  • phase iii
  • randomized controlled trial
  • double blind
  • air pollution